Greetings and welcome to the CV Sciences fourth quarter and year end, 2024 financial results conference call. At this time, all participants are in a listen-only mode. A brief question-and-answer ...

Q4 2024 Management View CEO Joseph Dowling highlighted the company’s focus on scaling its business, achieving cost efficiencies, and transitioning to a global health and wellness company. He noted a ...

The innovative, lemon-flavored fast-acting tablets provide a quick, uplifting experience, perfect for enhancing social moments or relaxing at home. SAN DIEGO, CA / ACCESS Newswire / February 5 ...

SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extra ...

The innovative product line offers a unique choice of plant-based, 100% natural alternatives to the foods everyone loves. SAN DIEGO, CA / ACCESS Newswire / March 26, 2025 / CV Sciences, Inc. (OTCQB:CV ...

Hemp-Focused CV Sciences Expands Via New Cannabis Acquisition, Here's What Investors Need To Know CV Sciences, Inc. (OTCQB: CVSI) a hemp-focused wellness company announced on Thursday it's ...

PlusCBD Oil™ by CV Sciences™ is in the business of developing, producing, marketing and selling raw materials and end-consumer hemp extracts containing cannabidiol (CBD). The primary focus is ...

The innovative, lemon-flavored fast-acting tablets provide a quick, uplifting experience, perfect for enhancing social moments or relaxing at home. SAN DIEGO, CA / ACCESS Newswire / February 5 ...